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Abstract
In living matter, shape fluctuations induced by acto-myosin are usually studied in vitro via reconstituted gels, whose proper-
ties are controlled by changing the concentrations of actin, myosin and cross-linkers. Such an approach deliberately avoids
to consider the complexity of biochemical signaling inherent to living systems. Acto-myosin activity inside living cells is
mainly regulated by the Rho signaling pathway which is composed of multiple layers of coupled activators and inhibitors.
We investigate how such a pathway controls the dynamics of confluent epithelial tissues by tracking the displacements of
the junction points between cells. Using a phenomenological model to analyze the vertex fluctuations, we rationalize the
effects of different Rho signaling targets on the emergent tissue activity by quantifying the effective diffusion coefficient, the
persistence time and persistence length of the fluctuations. Our results reveal an unanticipated correlation between layers of
activation/inhibition and spatial fluctuations within tissues. Overall, this work connects the regulation via biochemical sig-
naling with mesoscopic spatial fluctuations, with potential application to the study of structural rearrangements in epithelial
tissues.
∗These authors contributed equally to this work.
INTRODUCTION
Changes in shapes of cells and tissues are mediated by
the acto-myosin cytoskeleton. To reproduce the dynamics
of this network, minimal systems made of actin filaments,
myosin motors and cross-linkers are synthetized in vitro (1–
5). The mechanics and dynamics of such active gels are
controlled by varying the concentration of their various com-
ponents. Activity of each component is monitored by adding
some inhibitor drugs, and/or by tuning the ATP concen-
tration of the system. Recent experimental evidence have
shown the relevance of this approach to investigate the role
of motors and cross-linkers in the emerging properties of
the network (2, 6). These studies are based on tracking the
motion of tracers injected in active gels: analyzing the spon-
taneous fluctuations of such tracers enables one to extract
information about the activity of internal motors.
In multicellular systems, such as tissues of develop-
ing embryos, acto-myosin drives the morphogenesis: dra-
matic rearrangements leading to the formation of distinct
organs (7, 8). This remodelling is mainly under the con-
trol of intracellular activity, which powers spatial fluctua-
tions (9), and intercellular interactions mediated by adhesion
between neighboring cells (10, 11). In contrast to synthetic
gels, the internal regulation of the cellular acto-myosin activ-
ity is more complex in vivo. Therefore, extending the in
vitro approach, based on controlling externally the activity of
each specific component, to in vivo situations requires new
strategies.
The Rho signaling pathway is known to regulate the acto-
myosin activity in living cells (12). It also controls cell-cell
junctions (13) and the elasticity of stress fibers (14). Such a
pathway can be viewed as a series of activators and inhibitors
installing a hierarchy of potential targets (15, 16). Activa-
tions and inhibitions controlled by each target are such that
anticipating their net effects on the tissue fluctuations, pow-
ered by acto-myosin activity, remains a challenge (17, 18).
In that respect, the inherent complexity of internal activity
in vivo calls for new experiments and quantitative analysis
© 2013 The Authors
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2to bridge the biochemical signaling of the Rho pathway with
the emerging tissue dynamics.
In this paper, we explore the regulation of active fluc-
tuations by the Rho pathway in epithelial monolayers. We
measure these fluctuations by tracking tricellular junctions
or vertices over time. In contrast with active gels, our analy-
sis of internal fluctuations does not require to inject external
tracers. Based on a phenomenological model, we quantify
key parameters of junction activity: their effective diffusion
coefficient, as well as the persistence time and persistence
length of spatial fluctuations. We report modifications of
these parameters for various targets along the signaling path-
way. These results support that, for the inhibitions that we
considered, the active fluctuations of the vertices are reduced
when going downstream in the Rho pathway inhibition.
MATERIALS AND METHODS
Experiments were performed with MDCK II cells stably
expressing E-cadherin GFP (Nelson Lab.). We culture cells
in DMEM containing 10% Fetal Calf Serum (FCS) and
antibiotics. We replate them on glass coverslips (CS) of
25 mm diameter for live cell imaging. When the cell mono-
layer covered 70% of the CS area, we firmly place the sam-
ple at the bottom of a custom made metallic holder. For
acquisition, we change the medium to L15, 10% FCS and
antibiotics. We use the following inhibitors from myosin up
to Rho at optimal concentrations following the manufac-
turer recommendations: inhibition of acto-myosin by ML-7
(Sigma-Aldrich, 10 µM), inhibition of Rho kinase (ROCK)
by Y-27632 (Sigma-Aldrich, 10 µM), and inhibition of Rho
by C3 Transferase (Cytoskeleton, 0.04 µM). Note that the
use of blebbistatin to inhibit directly myosins yielded some
detrimental effects, leading us to rather use ML-7 instead.
For observation, we use a motorized inverted micro-
scope (Nikon Eclipse Ti), equipped with a 12 bit CCD
camera (Photometric CoolSNAP HQ2). The setup is tem-
perature controlled at 37◦C (Life Imaging Services). We
check with fluorescent beads (4 µm, TetraSpeck, Invitro-
gen Molecular Probes) grafted on CS surface that no drift
appears during 24 hours of live imaging after 2 hour sta-
bilization. We take pictures of the monolayer every 5 min
during the next 8 hours with multiple z-stacks 1 µm apart.
They span 3 µm depth of the cell monolayer. We merge the
z-stacks into one image by using the maximum intensity pro-
jection. We then extract vertex positions from the sequence
of merged images by manually clicking in each frame as
long as they are visible. The procedure was validated in its
precision through automatised detection as well. For each
condition, we check that the average cell area was always
about 180± 15 µm2, and we consider more than 20 vertices
for at least 3 biological repeats.
RESULTS
Vertex tracking and inhibitors in the Rho pathway
We use Madin Darby Canine Kidney (MDCK) cells sta-
bly transfected with E-cadherin fused with the Green Flu-
orescent Protein (GFP) as a paradigm for epithelial tis-
sues dynamics (19). This allows us to study live cells
while interacting with each other. We seek to identify spa-
tial points primarily involved in tissue transformations. The
meeting points between three cells are involved in exchanges
between neighbouring cells, thus serving as hallmark of tis-
sue dynamics (11, 20). Some specific proteins, such as tri-
cellulin, are known to accumulate at this point in cell culture.
Besides, vertices have also attracted the attention of develop-
mental biologists which exhibit accumulation of proteins at
these specific points (21).
Vertex dynamics are driven both by thermal fluctua-
tions and by active fluctuations powered by some inter-
nal nonequilibrium processes such as motor-induced forces,
actin polymerization and cell-cell adhesion. The myosin-II
motors are localized in dense contractile units present in
the apical surface of the tissue (22, 23) [Figs. 1(a-c)]. The
active forces lead to large displacements of the vertices dis-
tinct from the thermal fluctuations of smaller amplitude. We
focus here on large displacements which do not lead to any
topological transitions in the tissue [Figs. 1(d-e)]. The Rho
signaling pathway controls the acto-myosin activity inside
cells, namely the forces induced by myosin and/or by actin
polymerization (see Fig. 9 in (16)). In this study, we focus
on the downstream targets that affect myosin to establish the
principles for the validity and relevance of our framework.
Upstream and downstream targets install a hierarchy in the
activation of myosin. We specifically inhibit the following
targets: Rho, Rho kinase (ROCK) and myosin-II [Fig. 1(f)].
Each inhibitor is specific to its target and incubated at the
optimal concentrations for its inhibition. We used standard
concentration values already utilized in other cell biology
studies for many cell types including MDCK (24–27). Alto-
gether, we probe four conditions on the same system by
considering untreated cells as a control.
To demonstrate that the chosen inhibitors and their con-
centration specifically act on the contractile state of cells,
we investigate their effect on both architecture and contrac-
tile forces within tissues by measuring single cell area and
myosin cluster area in each condition. The distribution of
single cell area is not strongly affected in the myosin-II
inhibitor case compared with control, as apparent from the
mean value in Fig. 1(g). The distribution gets modified in
the Rho kinase and Rho inhibitor cases, with mean values
being slightly reduced and increased, respectively. In con-
trast, the polygonicity distribution remains approximately
the same for all conditions at different times, supporting that
tissue architecture is barely affected by external inhibitors
(see Fig. S1 in the Supporting Material).
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outs to assess the contractile state of cells (28, 29). Along
this line, measurements of cluster characteristics are infor-
mative. In our case, the mean density value of myosin clus-
ters for control is larger than in the inhibited cases (see
Figure 1: Study of vertex fluctuations. (a) Actin (red) and
myosin (green) structures at the apical surface of a MDCK
cell (scale bar 3 µm). The myosin is concentrated in dense
contractile units (yellow arrow) referred to as myosin clus-
ters. (b) Actin structure alone. (c) Myosin structure alone.
(d) We visualise MDCK cell monolayer by GFP E-cadherin
(scale bar 30 µm). (Inset) We identify the meeting points
between three cells as the privileged point for our analy-
sis (scale bar 4 µm). (e) Extraction of a typical transition
between two locally stable positions in vertex trajectory
(total time 8 hours). (f) Simplified diagram of the Rho path-
way installing an order relation in myosin activation, as pre-
sented in (16); in red the specific inhibitors and their targets.
(g) Area of individual cells in each condition. C: Control;
My: Myosin inhibitor; Rk: Rho kinase (ROCK) inhibitor; R:
Rho inhibitor. Number of experiments × number of cells =
C: 4×235; My: 4×246; Rk: 3×249; R: 3×148. (h) Area of
myosin clusters. Number of experiments × number of clus-
ters = C: 2 × 312; My: 2 × 186; Rk: 2 × 197; R: 2 × 257.
Statistical analysis with one-way ANOVA test: ns (non sig-
nificant) p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001
(see the Supporting Material).
Fig. S2 in the Supporting Material), suggesting a decrease
in force generation for the same level of myosin per cell. In
addition, the area of each myosin cluster is smaller in con-
trol than in other conditions [Fig. 1(h)]. Besides, this area
increases the more downstream along the Rho pathway inhi-
bition, suggesting a relaxation of the myosin pool in the
apical side, consistently with the notion that myosin-induced
forces are reduced. Altogether, our analysis of clusters con-
firms that we are acting on the contractile state of cells.
Since inhibitors are specific and used at their optimal con-
centrations, these measurements support the validity of our
experimental approach.
Statistics of vertex displacement: inhibitors affect
spatial fluctuations
Our goal is to investigate how the emergent fluctuations of
the tissue are regulated by the Rho pathway. To this aim,
we first demonstrate that the inhibitors in the pathway affect
these fluctuations by extracting the statistics of displace-
ments from the vertex trajectories. This allows us to assess
the existence of a direct link between biochemical signaling
and mechanical fluctuations. In our analysis, we do not con-
sider neither spatial inhomogeneities nor topological transi-
tions that occur in the tissues. In that respect, we measure
vertex trajectories in the absence of neighboring cell divi-
sion, by tracking them as long as they are visible until a
maximum of 8 hours.
We compute the projected one-dimensional mean square
displacement (MSD) within the four different conditions
[Fig. 2(a)]. For each condition, the short time MSD exhibits
a power-law behavior with exponent close to 0.7 over
about one decade. Interestingly, a subdiffusive behavior was
reported for the dynamics of vertices in the endoplasmic
reticulum (30). The large time MSD depends on conditions
and exhibits a behavior that, for simplicity, we have char-
acterized by a power-law. The corresponding exponent is
typically larger than 1, except for myosin inhibitor where it
is smaller. The crossover between the two regimes appears
between 20 and 60 min. Fluctuations are reduced in the
myosin inhibited case, which has the lowest MSD, and they
are enhanced for the Rho inhibitor, where the long time MSD
is the largest. We also explore the full statistics of vertex dis-
placement by measuring the probability distribution function
(PDF) for each condition, as shown in Figs. 2(b-e). At short
time the PDF is Gaussian, while it exhibits broader tails at
large time. These tails reveal large displacements of the ver-
tex, and were already observed for tracer particles in active
gels (31) and living cells (32–36). They are more pronounced
in the Rho inhibitor case, as a signature of larger fluctuations,
possibly due to directed motion events.
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displacement as a function of time in four conditions: con-
trol (black), myosin inhibitor (blue), Rho kinase inhibitor
(orange), and Rho inhibitor (red). The corresponding best
fitting curves are in solid lines. The blue and red dashed
lines report the large time behaviors. (b-e) Distribution of
displacement for the four conditions at three times: 5 (•), 25
(+), and 60 min (◦). Exponential tails appear at long times as
a consequence of directed motion events in vertex dynamics.
Results of simulated dynamics are in solid lines.
Phenomenological model of vertex dynamics: tran-
sient confinements and large displacements
To quantitatively discriminate between the effects of the
different inhibitors, we analyze our measurements with a
nonequilibrium model previously introduced to describe
tracer fluctuations inside living cells (36). This model is not
aimed at describing any specific process that produces the
active fluctuations, it rather formulates a general framework
that allows one to quantify non-equilibrium forces and fluc-
tuations. We regard the vertex as a virtual particle which
dynamics is prescribed by two coupled equations: (i) an
equilibrium diffusion of the vertex in a cage, modelled as an
harmonic potential of stiffness k—the displacement is driven
by a Gaussian white noise of variance 2γkBT with a drag
force of coefficient γ; (ii) a non-Gaussian colored diffusion
equation for the center of the cage, mimicking nonequilib-
rium activity as a run-and-tumble dynamics. Inspired by the
large ballistic-like displacements that we observe in experi-
mental trajectories, we model this active noise as a two-state
Poisson process: the cage has a constant velocity v in a ran-
dom uniformly sampled two-dimensional direction during a
random persistence time of average τ , and it remains fixed
during a random quiescence time of mean τ0. We understand
the confinement as an elastic mechanical stress resulting
from cells surrounding each vertex, and the nonequilibrium
motion of the cage as an active stress. The effect of this
active stress is to reorganize the structure of the monolayer,
and therefore to spatially redistribute the elastic mechanical
stress.
In the absence of activity, this model predicts a short
time diffusion, and then a large time plateau expressing the
elastic confinement. Such dynamics is entirely under the
control of equilibrium thermal fluctuations. In an active sys-
tem, nonequilibrium processes enhance vertex displacement
via the cage motion, yielding a free diffusion of the ver-
tex with coefficient DA = (vτ)2/[2(τ + τ0)]. The large
time dynamics is fully determined by the active parame-
ters {v, τ, τ0}, whereas thermal fluctuations control the short
times via {k, γ, T}. A sub-diffusive transient regime appears
between the two diffusions, as a crossover towards a plateau,
and a super-diffusive regime can also precede the large time
diffusion, as a signature of the ballistic motion involved in
the active noise. In such a case, thermal effects are negligi-
ble at times larger than τc =
√
τkBT/(kDA), a timescale
quantifying the transition from the short time equilibrium-
like dynamics to the large time active diffusion. Simulated
trajectories exhibit clusters of similar size accounting for the
transient confinement of the vertex. Occasionally large dis-
placements of order vτ appear. The vertices do not only fluc-
tuate around a local equilibrium position, they also undergo
rapid directed jumps (compare Fig. 1(e) and Fig. 3(a)).
In contrast to previous works which describe the many-
body dynamics of cells in the tissue in a more complete
framework (37–39), we do not explicitly account for inter-
actions between neighbouring vertices. As a result of such
interactions, the cells experience an intermittent dynam-
ics alternating between fluctuations of small amplitude and
rapid large displacements. As in glassy systems, the jumps
appear through collective rearranging regions (40), thus con-
tributing to the non-Gaussian fluctuations experienced by the
vertices. Even though non-Gaussian fluctuations are present
independently of topological transitions, the existence of a
quantitative connexion between collective rearrangements
and such transitions is still an open question (41). Our
approach consists in reducing the dynamics of a large num-
ber of interacting vertices into the dynamics of a single
vertex embedded in an effective background that describes
the mean-field effect of the surrounding system. Within our
model, interactions are embodied by both the elastic confine-
ment and the active source of fluctuations leading to large
Biophysical Journal 00(00) 1–8
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approach is sufficient to capture the vertex dynamics, since
it provides a framework to decipher the effects of the Rho
pathway inhibitions on this dynamics.
Order relation in the active diffusion coefficient and
the persistence time
We fit the MSD data with our analytic prediction to estimate
the parameters characterizing nonequilibrium activity. Our
fits convincingly capture the transition from sub-diffusive to
super-diffusive like behaviors [Fig. 2(a)]. Within our model,
these behaviors correspond to cross-over regimes between
the short and large time diffusion. We extract from the
best fits a single set of passive and active parameters for
each condition. Our estimate for τc can be compared with
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Figure 3: Active parameters of vertex fluctuations. (a) Typ-
ical trajectory obtained from simulations of the vertex
dynamics in control condition (scale bar 1 µm). Isotropic
“blobs” reveal equilibrium-like transient confinement during
a typical time τc (dashed blue box), and large displacements
of order vτ occur due to nonequilibrium activity (orange
arrows). (b) Best fit values of the active diffusion coeffi-
cient, (c) the persistence time, (d) the persistence length, and
(e) the energy dissipation rate. Statistical analysis with t-test:
ns (non significant) p > 0.05, * p < 0.05, ** p < 0.01, ***
p < 0.001 (see the Supporting Material).
timescales quantifying the transition from elastic to fluid-
like behavior of the material (see Tab. S1 in the Supporting
Material), which is of the same order as the Maxwell time
reported in three-dimensional cell agregates, i.e. about 30-
40 min (9, 42–44). We report clear quantitative variations
of both the active diffusion coefficient DA and the persis-
tence time τ for all conditions [Figs. 3(b,c)]. This suggests
that our model, based on separating purely active fluctua-
tions from equilibrium thermal ones, is a reliable framework
to capture the effects of our inhibitors on tissue dynamics.
Note that passive parameters, such as the relaxation time
scale τr = γ/k reported in Tab. S1 (see the Supporting
Material), have also different values between the conditions.
This reflects the effects of inhibitors on tissue mechanics,
showing that inhibitors also affects the characteristics of pas-
sive fluctuations. In this respect, DA and τ are the parame-
ters that characterize only the active contribution to vertex
fluctuations, which is the main focus of our study.
Strikingly, DA and τ are larger for Rho inhibitor than
for Rho kinase inhibitor, and than for direct myosin inhibi-
tion [Figs. 3(b,c)]. The more upstream the inhibition along
the pathway, the larger the amplitude of fluctuations and the
more persistent the ensuing displacement. The myosin inhi-
bition leads to the smallest DA and τ values, suggesting that
the mesoscopic activity of vertices is strongly affected. The
Rho kinase target directly activates the myosin, but it also
inhibits the myosin light chain phosphatase (MLCP) which
in turn inhibits the myosin. Therefore, the result of Rho
kinase inhibition on myosin can not be anticipated a priori.
Our analysis shows that activity of vertices is less affected
than for the myosin inhibitor case: the corresponding value
of DA for Rho kinase inhibitor is close to the one for con-
trol, which suggests a compensation between activation and
de-activation of myosin.
Order relation confirmed by persistence lengths
To gain further insight into the active component of the
dynamics, we compare the displacement PDF extracted from
the simulated trajectories of vertex dynamics with experi-
mental distributions. The distribution at short time is Gaus-
sian and entirely controlled by the passive parameters: the
simulations with or without active fluctuations, where we use
passive parameters estimated from fits of MSD data, give the
same results at short times (see yellow curves in Figs. 2(b-
e)). Including the active component for the dynamics leaves
us with one remaining free parameter: the average persis-
tence length vτ of large displacements. The short time Gaus-
sian remains unchanged, whereas exponential tails develop
at large times in the simulated PDF. The tails are more pro-
nounced as time increases, while the central Gaussian part
barely changes. We adjust the vτ value by matching the tails
appearing in numerical results and experimental data.
Biophysical Journal 00(00) 1–8
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ments at large times, showing that our simulations repro-
duce the evolution of experimental distributions at all times
[Figs. 2(b-e)]. This is one of the main success of our analy-
sis: the phenomenological model on which relies the quan-
tification of internal activity is able to capture the strong
non-Gaussian tails of the distribution with only one free
parameter. This supports the underlying picture that vertex
dynamics essentially alternates between transient confine-
ment and directed motions. The order of magnitude of the
extracted mean persistence length vτ is consistent with our
measurements [Fig. 3(d)]. We report again the same order
relation within the Rho pathway, i.e. an increase of vτ from
myosin inhibitor to Rho kinase inhibitor, and from Rho
kinase inhibitor to Rho inhibitor, as a signature of enhanced
directed motion.
Dissipation is constant for all inhibitors
A major asset of our model is that it allows us to predict
the mean rate of energy dissipated by the vertex dynamics
in its surrounding environment. It is defined as the differ-
ence between the power injected by the fluctuating ther-
mal force and the one that the moving vertex dissipates
via the drag force: J =
〈
x˙(γx˙−√2γkBTξ)
〉
, where x˙ is
the vertex velocity, and ξ is a zero-mean Gaussian white
noise (45, 46). It vanishes for systems in a thermodynamic
equilibrium state. The active nonequilibrium fluctuations
lead to a non zero dissipation rate: J = kDA/(1+τ/τr) (47).
This rate of dissipated energy reflects the excess power
injected by nonequilibrium internal activity driving the large
displacements of vertices.
When computing the dissipation rate in the four con-
ditions, it appears as approximately constant [Fig. 3(e)], in
contrast with the order relation found for active parameters
[Figs. 3(b-d)]. This supports that the same amount of energy
is dissipated by the vertex large displacements, though the
features of such displacements differ between conditions.
Given that J depends both on parameters of active fluc-
tuations {DA, τ} and on parameters of passive mechanics
{γ, k}, our result suggests that there may be an underlying
coupling between mechanical properties of the tissue and its
nonequilibrium fluctuations. A possible interpretation is that
the nonequilibrium processes at the origin of active fluctua-
tions, such as forces induced by myosin and by actin poly-
merization, might also affect the tissue mechanics in such
a way that the dissipation rate remains unchanged over all
the conditions. In that respect, we observe that the relaxation
time τr is increased for Rho inhibitor case with respect to oth-
ers (see Tab. S1 in the Supporting Material), as also observed
for the persistence time τ [Fig. 3(c)].
DISCUSSION
The parameters of vertex fluctuations reveal a correlation
between the Rho pathway hierarchy and the junction active
fluctuations: the higher up the Rho pathway is the inhibi-
tion, the lower is the effect on decreasing the fluctuations
of the vertices. Such a relation highlights the usefulness
of our methodology to probe quantitatively how signal-
ing pathways control emergent fluctuations. In that respect,
our approach bridges biochemical signaling pathways with
mechanical fluctuations in vivo. It could be used to char-
acterize quantitatively the effect on fluctuations of other
inhibitions acting on different signaling pathways.
Our analysis is based on a phenomenological model
which deliberately avoids a detailed description of the many
processes operating at the subcellular scale. It is also dis-
tinct from other models which consider explicit interac-
tions between neighbouring cells. In that respect, our results
do not rely neither on the microscopic details of activity-
induced forces nor on the form of interactions within the
tissue. We rather postulate an effective vertex dynamics by
explicitly distinguishing thermal and active fluctuations. As
a result, any underlying mechanism which could rational-
ize the relation between pathway inhibition and mechanical
fluctuations is out of the scope of our approach. Yet, the
relation between biochemical signaling and active fluctua-
tions that we quantified in tissues could help future studies
to understand the precise relation between the subcellular
cytoskeleton dynamics and the emergent vertex fluctuations.
In that respect, a possible extension of the model could con-
sist in considering more complex activation/inhibition in the
Rho pathway and their connection with contractile forces in
the cell (17, 18).
In order to test the robustness of our model, one could
measure the response of vertices to an external perturba-
tion (48). The intracellular mechanics is viscoelastic in
a large variety of living systems. Our phenomenological
model has already been extended to account for a complex
rheology (49). It would be interesting to determine whether
the relation between fluctuations and pathway inhibitions
is similar when including viscoelastic effects. Moreover,
applying an external potential to confine a vertex, one could
extract work from the vertex fluctuations by varying in time
the potential parameters. Our framework allows one to pre-
dict the details of the extracted work as a function of the
active fluctuation characteristics (47). Confronting such pre-
dictions with experimental results would provide another test
for the validity of our approach.
The response in living systems is not related to the spon-
taneous fluctuations, in contrast to equilibrium where such
a relation is given by the fluctuation-dissipation theorem
(FDT). Therefore, by comparing the response with sponta-
neous fluctuations of tissues, one could quantify the depar-
ture from the FDT, namely the deviation of the dynamics
Biophysical Journal 00(00) 1–8
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rium statistical mechanics have shed light on the direct rela-
tion between the rate of energy dissipated by the internal
nonequilibrium processes and the violation of the FDT (50).
This has already led to access to the dissipation rate in
some biological contexts (49, 51). In that respect, compar-
ing response and fluctuations will allow one to propose an
alternative quantification of dissipation rates in epithelial
tissues.
The Rho pathway is conserved across species, suggest-
ing that regulations of activity in epithelial monolayers may
share common pathways in a large variety of tissues and
organisms (12). Our approach, based on a quantitative anal-
ysis of vertex fluctuations, could serve as a novel framework
to decipher the complex regulation of spatial fluctuations by
the Rho pathway in other model systems. In that respect, it
could be used to analyze vertex fluctuations in developing
embryos, such as in Drosophila or in C. elegans, where inter-
nal reorganizations are driven by spontaneous topological
transitions (7, 8).
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